![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Malignant Lymphoma |
Free Subscription
6 Blood |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
Unraveling family ties in Hodgkin lymphoma.
Blood. 2023;141:1240-1241.
PubMed
Low-grade follicular lymphoma with extensive marginal zone differentiation and
expression of MUM1 and CD30.
Blood. 2023;141:1363.
PubMed
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma.
Blood. 2023 Mar 13:blood.2022019254. doi: 10.1182/blood.2022019254.
PubMed
Abstract available
Tumor microenvironment contribution to checkpoint blockade therapy. Lessons
learned from Hodgkin lymphoma.
Blood. 2023 Mar 10:blood.2022016590. doi: 10.1182/blood.2022016590.
PubMed
Abstract available
Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal
gray zone lymphoma.
Blood. 2023 Mar 10:blood.2022017951. doi: 10.1182/blood.2022017951.
PubMed
Synthetic lethality in ATL.
Blood. 2023;141:1096-1098.
PubMed
Low B-cell content is associated with a CD73-low tumour microenvironment and
unfavourable prognosis in classic Hodgkin lymphoma.
Br J Haematol. 2023 Mar 15. doi: 10.1111/bjh.18762.
PubMed
Abstract available
An illuminating piece in the jigsaw of Hodgkin lymphoma risk stratification.
Br J Haematol. 2023 Mar 17. doi: 10.1111/bjh.18764.
PubMed
Abstract available
Baseline metabolic tumour burden improves risk stratification in Hodgkin
lymphoma: A Children's Oncology Group study.
Br J Haematol. 2023 Mar 15. doi: 10.1111/bjh.18734.
PubMed
Abstract available
Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal
Diffuse Large B-cell Lymphoma.
Clin Med Insights Oncol. 2023;17:11795549231156692.
PubMed
Abstract available
Superiority of ibrutinib plus bendamustine and rituximab in newly diagnosed
patients with mantle-cell lymphoma ineligible for intensive therapy: a network
meta-analysis.
Eur J Haematol. 2023 Mar 14. doi: 10.1111/ejh.13953.
PubMed
Abstract available
The lymphoma microenvironment comes of age in the R-CHOP era?
Haematologica. 2023 Mar 16. doi: 10.3324/haematol.2022.282656.
PubMed
Abstract available
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large
B-cell lymphoma: the phase II AvR-CHOP study.
Leukemia. 2023 Mar 11. doi: 10.1038/s41375-023-01863.
PubMed
Abstract available
Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in
gastric diffuse large B‑cell lymphoma.
Oncol Rep. 2023;49:88.
PubMed
Abstract available
COVID-19 and non-Hodgkin's lymphoma: A common susceptibility pattern?
PLoS One. 2023;18:e0277588.
PubMed
Abstract available
Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective
Bruton's tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics.
PLoS One. 2023;18:e0282166.
PubMed
Abstract available
KMT2D acetylation by CREBBP reveals a cooperative functional interaction at
enhancers in normal and malignant germinal center B cells.
Proc Natl Acad Sci U S A. 2023;120:e2218330120.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by